HEADER PEPTIDOGLYCAN-BINDING PROTEIN 03-FEB-07 2EAX TITLE CRYSTAL STRUCTURE OF HUMAN PGRP-IBETAC IN COMPLEX WITH GLYCOSAMYL TITLE 2 MURAMYL PENTAPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDOGLYCAN RECOGNITION PROTEIN-I-BETA; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: PEPTIDOGLYCAN-BINDING DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GLYCOSAMYL MURAMYL PENTAPEPTIDE; COMPND 8 CHAIN: L; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PGRPIB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 OTHER_DETAILS: THE SEQUENCE OF THE PEPTIDE IS NATURALLY IN HUMAN. KEYWDS ALPHA/BETA, PEPTIDOGLYCAN-BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.CHO REVDAT 9 25-OCT-23 2EAX 1 HETSYN REVDAT 8 29-JUL-20 2EAX 1 COMPND REMARK HETNAM LINK REVDAT 8 2 1 SITE ATOM REVDAT 7 17-DEC-14 2EAX 1 HETATM LINK REVDAT 6 21-SEP-11 2EAX 1 HEADER KEYWDS REMARK SOURCE REVDAT 5 14-SEP-11 2EAX 1 HETATM HETNAM HETSYN FORMUL REVDAT 5 2 1 HET SITE REMARK REVDAT 4 27-JUL-11 2EAX 1 HETNAM HETSYN REMARK REVDAT 3 13-JUL-11 2EAX 1 VERSN REVDAT 2 24-FEB-09 2EAX 1 VERSN REVDAT 1 02-OCT-07 2EAX 0 JRNL AUTH S.CHO,Q.WANG,C.P.SWAMINATHAN,D.HESEK,M.LEE,G.J.BOONS, JRNL AUTH 2 S.MOBASHERY,R.A.MARIUZZA JRNL TITL STRUCTURAL INSIGHTS INTO THE BACTERICIDAL MECHANISM OF HUMAN JRNL TITL 2 PEPTIDOGLYCAN RECOGNITION PROTEINS JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 8761 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17502600 JRNL DOI 10.1073/PNAS.0701453104 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 27509 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.72 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3811 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2EAX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000026445. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27509 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2EAV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% (V/V) TACSIMATE, 0.1M HEPES PH REMARK 280 7.0, 2% (W/V) PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.69500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, L, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE ENTIRE CHAIN L (RESIDUES 500-506) IS GLYCOSAMYL MURAMYL REMARK 400 PENTAPEPTIDE. THE SEQUENCE IS NAG AMV ALA FGA LYS DAL DAL. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 390 O HOH C 596 2546 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 281 N - CA - C ANGL. DEV. = -18.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 271 -169.62 -161.86 REMARK 500 SER A 296 -12.78 -146.01 REMARK 500 ASN A 319 171.05 -58.19 REMARK 500 PRO A 357 36.14 -94.54 REMARK 500 HIS A 370 19.89 55.22 REMARK 500 ALA B 242 30.36 74.60 REMARK 500 GLN B 280 1.99 -65.73 REMARK 500 SER B 295 78.63 -155.19 REMARK 500 SER B 296 -12.89 -142.44 REMARK 500 PRO B 298 103.20 -56.21 REMARK 500 THR B 340 150.02 -41.45 REMARK 500 TYR B 343 172.12 -56.05 REMARK 500 PRO B 357 33.48 -95.40 REMARK 500 SER C 249 -72.35 -33.67 REMARK 500 PHE C 313 58.17 -114.69 REMARK 500 PRO C 357 32.82 -93.87 REMARK 500 DAL L 505 45.59 151.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2EAV RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN FREE FORM DBREF 2EAX A 210 373 UNP Q3B822 Q3B822_HUMAN 210 373 DBREF 2EAX B 210 373 UNP Q3B822 Q3B822_HUMAN 210 373 DBREF 2EAX C 210 373 UNP Q3B822 Q3B822_HUMAN 210 373 DBREF 2EAX L 502 506 PDB 2EAX 2EAX 502 506 SEQRES 1 A 164 CYS PRO GLY ILE VAL PRO ARG SER VAL TRP GLY ALA ARG SEQRES 2 A 164 GLU THR HIS CYS PRO ARG MET THR LEU PRO ALA LYS TYR SEQRES 3 A 164 GLY ILE ILE ILE HIS THR ALA GLY ARG THR CYS ASN ILE SEQRES 4 A 164 SER ASP GLU CYS ARG LEU LEU VAL ARG ASP ILE GLN SER SEQRES 5 A 164 PHE TYR ILE ASP ARG LEU LYS SER CYS ASP ILE GLY TYR SEQRES 6 A 164 ASN PHE LEU VAL GLY GLN ASP GLY ALA ILE TYR GLU GLY SEQRES 7 A 164 VAL GLY TRP ASN VAL GLN GLY SER SER THR PRO GLY TYR SEQRES 8 A 164 ASP ASP ILE ALA LEU GLY ILE THR PHE MET GLY THR PHE SEQRES 9 A 164 THR GLY ILE PRO PRO ASN ALA ALA ALA LEU GLU ALA ALA SEQRES 10 A 164 GLN ASP LEU ILE GLN CYS ALA MET VAL LYS GLY TYR LEU SEQRES 11 A 164 THR PRO ASN TYR LEU LEU VAL GLY HIS SER ASP VAL ALA SEQRES 12 A 164 ARG THR LEU SER PRO GLY GLN ALA LEU TYR ASN ILE ILE SEQRES 13 A 164 SER THR TRP PRO HIS PHE LYS HIS SEQRES 1 B 164 CYS PRO GLY ILE VAL PRO ARG SER VAL TRP GLY ALA ARG SEQRES 2 B 164 GLU THR HIS CYS PRO ARG MET THR LEU PRO ALA LYS TYR SEQRES 3 B 164 GLY ILE ILE ILE HIS THR ALA GLY ARG THR CYS ASN ILE SEQRES 4 B 164 SER ASP GLU CYS ARG LEU LEU VAL ARG ASP ILE GLN SER SEQRES 5 B 164 PHE TYR ILE ASP ARG LEU LYS SER CYS ASP ILE GLY TYR SEQRES 6 B 164 ASN PHE LEU VAL GLY GLN ASP GLY ALA ILE TYR GLU GLY SEQRES 7 B 164 VAL GLY TRP ASN VAL GLN GLY SER SER THR PRO GLY TYR SEQRES 8 B 164 ASP ASP ILE ALA LEU GLY ILE THR PHE MET GLY THR PHE SEQRES 9 B 164 THR GLY ILE PRO PRO ASN ALA ALA ALA LEU GLU ALA ALA SEQRES 10 B 164 GLN ASP LEU ILE GLN CYS ALA MET VAL LYS GLY TYR LEU SEQRES 11 B 164 THR PRO ASN TYR LEU LEU VAL GLY HIS SER ASP VAL ALA SEQRES 12 B 164 ARG THR LEU SER PRO GLY GLN ALA LEU TYR ASN ILE ILE SEQRES 13 B 164 SER THR TRP PRO HIS PHE LYS HIS SEQRES 1 C 164 CYS PRO GLY ILE VAL PRO ARG SER VAL TRP GLY ALA ARG SEQRES 2 C 164 GLU THR HIS CYS PRO ARG MET THR LEU PRO ALA LYS TYR SEQRES 3 C 164 GLY ILE ILE ILE HIS THR ALA GLY ARG THR CYS ASN ILE SEQRES 4 C 164 SER ASP GLU CYS ARG LEU LEU VAL ARG ASP ILE GLN SER SEQRES 5 C 164 PHE TYR ILE ASP ARG LEU LYS SER CYS ASP ILE GLY TYR SEQRES 6 C 164 ASN PHE LEU VAL GLY GLN ASP GLY ALA ILE TYR GLU GLY SEQRES 7 C 164 VAL GLY TRP ASN VAL GLN GLY SER SER THR PRO GLY TYR SEQRES 8 C 164 ASP ASP ILE ALA LEU GLY ILE THR PHE MET GLY THR PHE SEQRES 9 C 164 THR GLY ILE PRO PRO ASN ALA ALA ALA LEU GLU ALA ALA SEQRES 10 C 164 GLN ASP LEU ILE GLN CYS ALA MET VAL LYS GLY TYR LEU SEQRES 11 C 164 THR PRO ASN TYR LEU LEU VAL GLY HIS SER ASP VAL ALA SEQRES 12 C 164 ARG THR LEU SER PRO GLY GLN ALA LEU TYR ASN ILE ILE SEQRES 13 C 164 SER THR TRP PRO HIS PHE LYS HIS SEQRES 1 L 5 ALA FGA LYS DAL DAL HET FGA L 503 9 HET DAL L 505 5 HET DAL L 506 6 HET AMV D 1 20 HET NAG D 2 14 HETNAM FGA GAMMA-D-GLUTAMIC ACID HETNAM DAL D-ALANINE HETNAM AMV METHYL 2-ACETAMIDO-3-O-[(1R)-1-CARBOXYETHYL]-2-DEOXY- HETNAM 2 AMV BETA-D-GLUCOPYRANOSIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN FGA D-GLUTAMIC ACID HETSYN AMV METHYL 2-(ACETYLAMINO)-3-O-[(1R)-1-CARBOXYETHYL]-2- HETSYN 2 AMV DEOXY-BETA-D-GLUCOPYRANOSIDE; METHYL 2-ACETAMIDO-3-O- HETSYN 3 AMV [(1R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOSIDE; METHYL HETSYN 4 AMV 2-ACETAMIDO-3-O-[(1R)-1-CARBOXYETHYL]-2-DEOXY-D- HETSYN 5 AMV GLUCOSIDE; METHYL 2-ACETAMIDO-3-O-[(1R)-1- HETSYN 6 AMV CARBOXYETHYL]-2-DEOXY-GLUCOSIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 FGA C5 H9 N O4 FORMUL 4 DAL 2(C3 H7 N O2) FORMUL 5 AMV C12 H21 N O8 FORMUL 5 NAG C8 H15 N O6 FORMUL 6 HOH *320(H2 O) HELIX 1 1 PRO A 215 GLY A 220 1 6 HELIX 2 2 ILE A 248 ARG A 266 1 19 HELIX 3 3 TYR A 300 ASP A 302 5 3 HELIX 4 4 ASN A 319 LYS A 336 1 18 HELIX 5 5 SER A 349 ALA A 352 5 4 HELIX 6 6 GLY A 358 SER A 366 1 9 HELIX 7 7 PRO B 215 GLY B 220 1 6 HELIX 8 8 ILE B 248 ARG B 266 1 19 HELIX 9 9 TYR B 300 ASP B 302 5 3 HELIX 10 10 ASN B 319 LYS B 336 1 18 HELIX 11 11 SER B 349 ALA B 352 5 4 HELIX 12 12 GLY B 358 SER B 366 1 9 HELIX 13 13 PRO C 215 GLY C 220 1 6 HELIX 14 14 ILE C 248 ARG C 266 1 19 HELIX 15 15 TYR C 300 ASP C 302 5 3 HELIX 16 16 ASN C 319 LYS C 336 1 18 HELIX 17 17 SER C 349 VAL C 351 5 3 HELIX 18 18 GLY C 358 SER C 366 1 9 SHEET 1 A 6 ILE A 213 VAL A 214 0 SHEET 2 A 6 ILE A 284 GLU A 286 1 O ILE A 284 N VAL A 214 SHEET 3 A 6 PHE A 276 VAL A 278 -1 N LEU A 277 O TYR A 285 SHEET 4 A 6 ALA A 304 PHE A 309 1 O THR A 308 N PHE A 276 SHEET 5 A 6 ALA A 233 HIS A 240 1 N ILE A 237 O ILE A 307 SHEET 6 A 6 LEU A 339 GLY A 347 1 O LEU A 344 N LYS A 234 SHEET 1 B 6 ILE B 213 VAL B 214 0 SHEET 2 B 6 ILE B 284 GLU B 286 1 O ILE B 284 N VAL B 214 SHEET 3 B 6 PHE B 276 VAL B 278 -1 N LEU B 277 O TYR B 285 SHEET 4 B 6 ALA B 304 PHE B 309 1 O THR B 308 N PHE B 276 SHEET 5 B 6 ALA B 233 HIS B 240 1 N ILE B 237 O ILE B 307 SHEET 6 B 6 LEU B 339 GLY B 347 1 O VAL B 346 N GLY B 236 SHEET 1 C 6 ILE C 213 VAL C 214 0 SHEET 2 C 6 ILE C 284 GLU C 286 1 O ILE C 284 N VAL C 214 SHEET 3 C 6 PHE C 276 VAL C 278 -1 N LEU C 277 O TYR C 285 SHEET 4 C 6 ALA C 304 PHE C 309 1 O GLY C 306 N PHE C 276 SHEET 5 C 6 ALA C 233 HIS C 240 1 N ILE C 239 O PHE C 309 SHEET 6 C 6 LEU C 339 GLY C 347 1 O THR C 340 N ALA C 233 SSBOND 1 CYS A 210 CYS A 332 1555 1555 2.04 SSBOND 2 CYS A 226 CYS A 270 1555 1555 2.03 SSBOND 3 CYS A 246 CYS A 252 1555 1555 2.04 SSBOND 4 CYS B 210 CYS B 332 1555 1555 2.03 SSBOND 5 CYS B 226 CYS B 270 1555 1555 2.04 SSBOND 6 CYS B 246 CYS B 252 1555 1555 2.04 SSBOND 7 CYS C 210 CYS C 332 1555 1555 2.03 SSBOND 8 CYS C 226 CYS C 270 1555 1555 2.03 SSBOND 9 CYS C 246 CYS C 252 1555 1555 2.05 LINK C ALA L 502 N FGA L 503 1555 1555 1.33 LINK N ALA L 502 C10 AMV D 1 1555 1555 1.33 LINK CD FGA L 503 N LYS L 504 1555 1555 1.33 LINK C LYS L 504 N DAL L 505 1555 1555 1.33 LINK C DAL L 505 N DAL L 506 1555 1555 1.33 LINK O4 AMV D 1 C1 NAG D 2 1555 1555 1.44 CISPEP 1 LEU A 231 PRO A 232 0 -0.07 CISPEP 2 SER A 356 PRO A 357 0 -0.06 CISPEP 3 LEU B 231 PRO B 232 0 -0.17 CISPEP 4 SER B 356 PRO B 357 0 -0.10 CISPEP 5 LEU C 231 PRO C 232 0 -0.12 CISPEP 6 SER C 356 PRO C 357 0 0.07 CRYST1 41.940 61.390 97.950 90.00 96.45 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023844 0.000000 0.002696 0.00000 SCALE2 0.000000 0.016289 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010274 0.00000